| 摘要 |
<p>5The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood dotting inhibitor for preventing adverse effects in a patient. The type of patient that my benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient10 undergoing non-vascular surgery, or a fetus during labor and delivery. No suitable figure</p> |
